Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_assertion type Assertion NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_head.
- NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_assertion description "[The FAB M0 subtype was more frequent in ETV6 rearranged de novo AML than other AML (P < 0.001); expression of CD7 and CD34 by immunophenotyping was higher in ETV6 rearranged AML compared with other subgroups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_provenance.
- NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_assertion evidence source_evidence_literature NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_provenance.
- NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_assertion SIO_000772 22162288 NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_provenance.
- NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_assertion wasDerivedFrom befree-20140225 NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_provenance.
- NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_assertion wasGeneratedBy ECO_0000203 NP705271.RA39MY-EuZ9O_ZPj5jwzYnD0aCGbQsSFOrX6iDo2RSrfo130_provenance.